ACG partnered with Art of You to launch the world-first Personalised Capsule Machine, enabling on-demand, customized supplement capsules based on individual health data.
· ACG’s PCM enables on-demand production of personalized capsules using real-time health data, precise dosing, and automated manufacturing.
· The ACG–AoY partnership combines advanced capsule tech and formulation expertise to create science-backed, customized supplements.
· With 1,500+ machines planned in Europe and €500M revenue forecasted, PCM shows strong commercial potential for scalable personalized nutrition.
A group of antibiotic pill capsules falling. Healthcare and medical 3D illustration background | Image Credit: © James Thew - stock.adobe.com
Thanks to an exclusive partnership with Art of You (AoY)—a personalized supplement development company—the ACG Group (ACG) announced its world-first Personalised Capsule Machine (PCM) for creating custom-formulated supplement capsules that can be individualized on demand to the specific needs of a given patient (1). As a fully integrated manufacturing solutions provider for the global pharmaceutical and nutraceutical industries, ACG developed PCM to create individualized supplements by merging precise dosing, real-time health data, and automated capsule production.
The AoY–ACG partnership integrates AoY’s formulation knowledge and experience along with ACG’s beadlet and capsule technologies to create a one-of-a-kind system for delivering bespoke supplement solutions that match individuals’ biomarkers, lifestyle choices, and health goals.
“After five years in development, we are thrilled to launch the PCM and collaborate with Art of You on this groundbreaking initiative. It represents a true leap forward in personalised [sic] nutrition,” said Aaron Quinn, senior manager for Europe at Vantage Nutrition, part of the ACG Group. “This partnership underscores our commitment to growth through innovation and focus on advancing health solutions globally. With over 1,500 PCM machines planned for deployment across Europe in the next five years and projected revenue of more than €500 million over the next three, this initiative highlights ACG’s leadership in delivering cutting-edge capsule and beadlet technologies to the market.”
Adding to Quinn’s sentiments, AoY Co-Founder Pablo Smolders said “We are proud to showcase this exciting new collaboration at Vitafoods Europe. By leveraging ACG’s exceptional capsule technologies alongside our own expertise, we are bringing our vision of science-backed, personalised wellness closer to reality.”
The news comes as AoY team members are joining ACG at Vitafoods Europe, held May 20-22 in Barcelona (2), where they’re discussing the science, vision, and technology that helped that innovation come to life.Also at the show, ACG’s Vantage Nutrition division is presenting “advanced ingredient delivery technologies including controlled release beadlets, liquid-filled hard capsules, and cap-in-cap dosing solutions,” according to a press release shared by ACG (1).
PCM, according to ACG, is able to deliver:
Back in January, ACG showcased it’s line of sustainable packaging solutions at Pharmapack Europe. In particular, ACG highlighted its CelluPod paper-based, recyclable, and compostable blister system for products that require low water vapor transmission rates (WVTR). The company also featured its packaging solutions that are free of polyvinyl chloride (PVC). These include its PVC and Halogen-Free Thermoforming Blister System for products requiring low to medium WVTR. ACG also provides an eco-friendly alternative in its Bio D PVC. The company’s Halogen-Free Cold Form Blister System also provides a high-performance sustainable solution without halogen and PVC.
In October 2024, Pharmaceutical Technology EuropeTM sat down Anil Andrade, vice-president of Global Sales at ACG World, during CPHI Milan to discuss growth in demand in the pharma industry and efforts put forth to achieve sustainable operations. In the interview, Andrade talked about the changing perceptions of the industry and the importance of sustainability in pharmaceutical operations. During the past 10 to 15 years, ACG has seen global growth in demand, and more so in Europe, North America, and Asia. Andrade also emphasized efforts to achieve sustainability to reduce the impact on the environment (3).
“Manufacturing capsules consumes a lot of water, and we have been trying to make our operations more efficient so that they consume less water, less paper, less plastic,” Andrade explained. “In Croatia, as an example, we have reduced the paper consumption by almost 25 tons in a year. Same with plastic, we have reduced the consumption of plastic by 25 tons, and that has related to the benefits that we see going forward.”
Listen to the full interview with Andrade!
References
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
